BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22058145)

  • 1. Risk modification of colorectal adenoma by CYP7A1 polymorphisms and the role of bile acid metabolism in carcinogenesis.
    Wertheim BC; Smith JW; Fang C; Alberts DS; Lance P; Thompson PA
    Cancer Prev Res (Phila); 2012 Feb; 5(2):197-204. PubMed ID: 22058145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender, but not CYP7A1 or SLCO1B1 polymorphism, affects the fasting plasma concentrations of bile acids in human beings.
    Xiang X; Backman JT; Neuvonen PJ; Niemi M
    Basic Clin Pharmacol Toxicol; 2012 Mar; 110(3):245-52. PubMed ID: 21902813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphism of cholesterol 7alpha-hydroxylase (CYP7A1) and colorectal adenomas: Self Defense Forces Health Study.
    Tabata S; Yin G; Ogawa S; Yamaguchi K; Mineshita M; Kono S
    Cancer Sci; 2006 May; 97(5):406-10. PubMed ID: 16630139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ursodeoxycholic acid on the gut microbiome and colorectal adenoma development.
    Pearson T; Caporaso JG; Yellowhair M; Bokulich NA; Padi M; Roe DJ; Wertheim BC; Linhart M; Martinez JA; Bilagody C; Hornstra H; Alberts DS; Lance P; Thompson PA
    Cancer Med; 2019 Feb; 8(2):617-628. PubMed ID: 30652422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between Circulating Vitamin D Metabolites and Fecal Bile Acid Concentrations.
    Jacobs ET; Haussler MR; Alberts DS; Kohler LN; Lance P; Martínez ME; Roe DJ; Jurutka PW
    Cancer Prev Res (Phila); 2016 Jul; 9(7):589-97. PubMed ID: 27138789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor 1498C/T, 936C/T polymorphisms associated with increased risk of colorectal adenoma: a Chinese case-control study.
    Wu X; Li D; Liu Z; Wan X; Wu Y; Jiang C; Qian Q
    Mol Biol Rep; 2011 Mar; 38(3):1949-55. PubMed ID: 20857215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in bile acid composition and effect on cytolytic activity of fecal water by ursodeoxycholic acid administration: a placebo-controlled cross-over intervention trial in healthy volunteers.
    van Gorkom BA; van der Meer R; Boersma-van Ek W; Termont DS; de Vries EG; Kleibeuker JH
    Scand J Gastroenterol; 2002 Aug; 37(8):965-71. PubMed ID: 12229974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of ursodeoxycholic acid on the relative expression of the lipid metabolism genes in mouse cholesterol gallstone models.
    Fan N; Meng K; Zhang Y; Hu Y; Li D; Gao Q; Wang J; Li Y; Wu S; Cui Y
    Lipids Health Dis; 2020 Jul; 19(1):158. PubMed ID: 32615989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender modifies the effect of ursodeoxycholic acid in a randomized controlled trial in colorectal adenoma patients.
    Thompson PA; Wertheim BC; Roe DJ; Ashbeck EL; Jacobs ET; Lance P; Martínez ME; Alberts DS
    Cancer Prev Res (Phila); 2009 Dec; 2(12):1023-30. PubMed ID: 19952360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence.
    Alberts DS; Martínez ME; Hess LM; Einspahr JG; Green SB; Bhattacharyya AK; Guillen J; Krutzsch M; Batta AK; Salen G; Fales L; Koonce K; Parish D; Clouser M; Roe D; Lance P;
    J Natl Cancer Inst; 2005 Jun; 97(11):846-53. PubMed ID: 15928305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP7A1 (-204 A>C; rs3808607 and -469 T>C; rs3824260) promoter polymorphisms and risk of gallbladder cancer in North Indian population.
    Srivastava A; Choudhuri G; Mittal B
    Metabolism; 2010 Jun; 59(6):767-73. PubMed ID: 20005541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linkage disequilibrium blocks, haplotype structure, and htSNPs of human CYP7A1 gene.
    Nakamoto K; Wang S; Jenison RD; Guo GL; Klaassen CD; Wan YJ; Zhong XB
    BMC Genet; 2006 May; 7():29. PubMed ID: 16709249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphism in cytochrome P450 7A1 and risk of colorectal cancer: the Fukuoka Colorectal Cancer Study.
    Hagiwara T; Kono S; Yin G; Toyomura K; Nagano J; Mizoue T; Mibu R; Tanaka M; Kakeji Y; Maehara Y; Okamura T; Ikejiri K; Futami K; Yasunami Y; Maekawa T; Takenaka K; Ichimiya H; Imaizumi N
    Cancer Res; 2005 Apr; 65(7):2979-82. PubMed ID: 15805302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of a phase I multiple-dose clinical study of ursodeoxycholic Acid.
    Hess LM; Krutzsch MF; Guillen J; Chow HH; Einspahr J; Batta AK; Salen G; Reid ME; Earnest DL; Alberts DS
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):861-7. PubMed ID: 15159320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: an observational study.
    Serfaty L; De Leusse A; Rosmorduc O; Desaint B; Flejou JF; Chazouilleres O; Poupon RE; Poupon R
    Hepatology; 2003 Jul; 38(1):203-9. PubMed ID: 12830003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of farnesoid X receptor coactivator recruitment and cholesterol 7alpha-hydroxylase gene repression by bile acids.
    Bramlett KS; Yao S; Burris TP
    Mol Genet Metab; 2000 Dec; 71(4):609-15. PubMed ID: 11136553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol feeding of mice expressing cholesterol 7alpha-hydroxylase increases bile acid pool size despite decreased enzyme activity.
    Tiemann M; Han Z; Soccio R; Bollineni J; Shefer S; Sehayek E; Breslow JL
    Proc Natl Acad Sci U S A; 2004 Feb; 101(7):1846-51. PubMed ID: 14762172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternate pathways of bile acid synthesis in the cholesterol 7alpha-hydroxylase knockout mouse are not upregulated by either cholesterol or cholestyramine feeding.
    Schwarz M; Russell DW; Dietschy JM; Turley SD
    J Lipid Res; 2001 Oct; 42(10):1594-603. PubMed ID: 11590215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of genes involved in bile acid synthesis with the progression of primary biliary cirrhosis in Japanese patients.
    Inamine T; Higa S; Noguchi F; Kondo S; Omagari K; Yatsuhashi H; Tsukamoto K; Nakamura M
    J Gastroenterol; 2013 Oct; 48(10):1160-70. PubMed ID: 23354620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barley β-glucan reduces blood cholesterol levels via interrupting bile acid metabolism.
    Wang Y; Harding SV; Thandapilly SJ; Tosh SM; Jones PJH; Ames NP
    Br J Nutr; 2017 Nov; 118(10):822-829. PubMed ID: 29115200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.